Suppr超能文献

为新冠疫苗接种制定合理的公共卫生政策决策:疫苗有效性、安全性、可负担性、规划物流及全球推广。

Making sound public health policy decisions for COVID-19 vaccination: vaccine effectiveness, safety, affordability, programmatic logistics and roll-out globally.

作者信息

Choudhary Om Prakash, Singh Indraj

机构信息

Department of Veterinary Anatomy and Histology, College of Veterinary Sciences and Animal Husbandry, Central Agricultural University (I), Selesih, Aizawl, 796015, Mizoram, India.

Medical Superintendent, Community Health Centre, Deoband, Saharanpur, 247554, Uttar Pradesh, India.

出版信息

J Travel Med. 2021 Mar 5. doi: 10.1093/jtm/taab031.

Abstract

Highlight/Teaser The universal mitigation of the pandemic triggered by severe acute respiratory syndrome coronavirus 2 relies on successfully implementing a fast-paced immunization program based on an efficient framework encompassing the in-field logistics of the vaccine distribution, coverage and efficacy. The forthcoming challenges and resolution plans for executing the coronavirus disease 2019 vaccination have been comprehensively outlined in the present discourse.

摘要

重点/概述 由严重急性呼吸综合征冠状病毒2引发的大流行的全面缓解,依赖于在一个高效框架基础上成功实施快速免疫计划,该框架涵盖疫苗分发、覆盖范围和效力的现场物流。本文全面概述了2019冠状病毒病疫苗接种即将面临的挑战和解决方案。

相似文献

3
Effects of adjusting public health, travel, and social measures during the roll-out of COVID-19 vaccination: a modelling study.
Lancet Public Health. 2021 Sep;6(9):e674-e682. doi: 10.1016/S2468-2667(21)00167-5. Epub 2021 Aug 11.
4
A framework for monitoring population immunity to SARS-CoV-2.
Ann Epidemiol. 2021 Nov;63:75-78. doi: 10.1016/j.annepidem.2021.08.013. Epub 2021 Aug 21.
5
[Technical guidelines for seasonal influenza vaccination in China (2021-2022)].
Zhonghua Liu Xing Bing Xue Za Zhi. 2021 Oct 10;42(10):1722-1749. doi: 10.3760/cma.j.cn112338-20210913-00732.
6
Developing COVID-19 vaccine recommendations during the pandemic: The experience of Serbia's Expert Committee on Immunization.
Front Public Health. 2022 Nov 17;10:1056670. doi: 10.3389/fpubh.2022.1056670. eCollection 2022.
9
Global caregiver perspectives on COVID-19 immunization in childhood cancer: A qualitative study.
Front Public Health. 2023 Mar 7;11:1004263. doi: 10.3389/fpubh.2023.1004263. eCollection 2023.

引用本文的文献

1
Environmental Health Risk Evaluation and Potential to Cause Disease X as a Global Pandemic: A Call for Global Preparedness.
Health Sci Rep. 2025 May 26;8(5):e70864. doi: 10.1002/hsr2.70864. eCollection 2025 May.
2
Vaccine skepticism and vaccine development stages; inoculation from "cowpox" lesion to the current mRNA vaccine of COVID-19: review.
Ther Adv Vaccines Immunother. 2024 Oct 11;12:25151355241288135. doi: 10.1177/25151355241288135. eCollection 2024.
3
Saudi Arabia's Middle East respiratory syndrome Coronavirus (MERS-CoV) outbreak: consequences, reactions, and takeaways.
Ann Med Surg (Lond). 2024 Jul 1;86(8):4668-4674. doi: 10.1097/MS9.0000000000002336. eCollection 2024 Aug.
5
Healthcare workers' knowledge and risk perception regarding the first wave of COVID-19 in Khyber Pakhtunkhwa, Pakistan: an online cross-sectional survey.
Ann Med Surg (Lond). 2024 Mar 6;86(5):2562-2571. doi: 10.1097/MS9.0000000000001916. eCollection 2024 May.
8
Uptake, Safety and Attitudes Towards COVID-19 Vaccination: A Cross-Sectional Study on First and Second Doses Among the General Public.
Risk Manag Healthc Policy. 2023 Aug 18;16:1633-1643. doi: 10.2147/RMHP.S418300. eCollection 2023.
9
In-silico approach to designing effective antiviral drugs against SARS-CoV-2 and SARS-CoV-1 from reported phytochemicals: a quality improvement study.
Ann Med Surg (Lond). 2023 Jun 8;85(7):3446-3460. doi: 10.1097/MS9.0000000000000839. eCollection 2023 Jul.
10
An extended SEIRDV compartmental model: case studies of the spread of COVID-19 and vaccination in Tunisia and South Africa.
Ann Med Surg (Lond). 2023 Apr 18;85(6):2721-2730. doi: 10.1097/MS9.0000000000000627. eCollection 2023 Jun.

本文引用的文献

1
Modelling of COVID-19 vaccination strategies and herd immunity, in scenarios of limited and full vaccine supply in NSW, Australia.
Vaccine. 2022 Apr 14;40(17):2506-2513. doi: 10.1016/j.vaccine.2021.04.042. Epub 2021 Apr 24.
2
Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment.
Lancet. 2021 Mar 13;397(10278):1023-1034. doi: 10.1016/S0140-6736(21)00306-8. Epub 2021 Feb 12.
3
Looking beyond COVID-19 vaccine phase 3 trials.
Nat Med. 2021 Feb;27(2):205-211. doi: 10.1038/s41591-021-01230-y. Epub 2021 Jan 19.
4
Clinical Outcomes Of A COVID-19 Vaccine: Implementation Over Efficacy.
Health Aff (Millwood). 2021 Jan;40(1):42-52. doi: 10.1377/hlthaff.2020.02054. Epub 2020 Nov 19.
5
SARS-CoV-2 and COVID-19: The most important research questions.
Cell Biosci. 2020 Mar 16;10:40. doi: 10.1186/s13578-020-00404-4. eCollection 2020.
6
Vaccine production, distribution, access, and uptake.
Lancet. 2011 Jul 30;378(9789):428-38. doi: 10.1016/S0140-6736(11)60478-9. Epub 2011 Jun 12.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验